(NP (NP (NN Eosinophil) (NN priming)) (PP (IN by) (NP (NNS cytokines))) (: :) (PP-COOD (PP (IN from) (NP (JJ cellular) (NN signal))) (PP (TO to) (NP (ADJP (FW in) (FW vivo)) (NN modulation)))) (. .))
(S (NP-SBJ (NNS Eosinophils)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NP (DT the) (NN effector) (NN phase)) (PP (IN of) (NP (JJ allergic) (NN inflammation)))))) (. .))
(S (NP-SBJ (DT This) (NN review)) (VP (MD will) (VP (VB focus) (PP (IN on) (NP (NP (NP (DT the) (NN conversion)) (PP (IN of) (NP (NP (DT the) (JJ unprimed) (NN eosinophil) (NN phenotype)) (PP (IN in) (NP (NP (DT the) (JJ peripheral) (NN blood)) (PP (IN of) (NP (JJ normal) (NNS individuals))))))) (PP (TO to) (NP (NP (DT the) (JJ primed) (NN phenotype)) (VP (VBN found) (NP (-NONE- *)) (PP (IN in) (NP (NP (DT the) (JJ peripheral) (NP-COOD (NP (NN blood)) (CC and) (NP (NNS tissues)))) (PP (IN of) (NP (JJ allergic) (NNS patients))))))))) (, ,) (NP (NP (DT a) (NN phenomenon)) (VP (VBN called) (S (NP-SBJ (-NONE- *)) (NP-PRD (NN priming))))))))) (. .))
(S (NP-SBJ-45 (NP (JJ Recent) (NNS data)) (PP (IN on) (NP (NP (DT the) (NNS signals)) (VP (VBN initiated) (NP (-NONE- *)) (PP-TMP (IN after) (NP (NP (NN cytokine) (NN receptor) (NN activation)) (PP (IN on) (NP (NNS eosinophils))))))))) (VP (MD will) (VP (VB be) (VP (VBN reviewed) (NP (-NONE- *-45))))) (. .))
